Neogen Corp (NEOG) stock
Close on Nov 12, 2026Market cap $2.44BP/E –Yield –
Neogen Corp saw revenue fall 0.3% to $883.99M over the twelve months to Aug 31, 2026. Free cash flow was $49.80M. At the latest close the market valued the company at $2.44B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Aug 31, 2026
Valuation
- Market cap
- $2.44B
- P/E ratio
- –
- Price to sales
- 2.76
- Price to book
- 1.17
- Dividend yield
- –
- Free cash flow yield
- 2.04%
Fundamentals
- Revenue
- $883.99M
- Net income
- -$56.12M
- EPS, diluted
- -$0.25
- Free cash flow
- $49.80M
- Book value per share
- $9.57
- Diluted shares
- 218M
Trading
- Next earnings
- Jan 7, 2027 (estimated, before the open)
- Previous close
- $11.60
- Open
- $11.45
- Day's range
- $11.18 – $11.56
- Volume
- 1,631,501
- Average volume (20 days)
- 3,010,526
- Index membership
- S&P SmallCap 600 (since May 2025), Russell 2000, Russell 3000
- Beta (5 years)
- 1.19
- 52-week range
- $5.37 – $14.26
- RSI (14 days)
- 39.4
- Volatility (1 year)
- 57.9%
- Relative volume
- 0.53×
- WACC
- 8.8%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | NEOG | S&P 500 | Difference | NEOG per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -6.8% | -2.7% | −4.1 pts | ||
| 3 months | -2.4% | -1.7% | −0.6 pts | ||
| Year to date | +60.1% | +11.9% | +48.2 pts | ||
| 1 year | +73.0% | +12.0% | +61.0 pts | ||
| 3 years | -25.9% | +78.2% | −104.1 pts | -9.5% | +21.2% |
| 5 years | -74.7% | +73.2% | −148.0 pts | -24.1% | +11.6% |
| 10 years | -51.4% | +309.6% | −361.1 pts | -7.0% | +15.1% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Neogen filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- News
- Results
About Neogen
In Vitro & In Vivo Diagnostic Substances
Neogen Corporation develops, manufactures, and markets food and animal safety products and services. The Food Safety segment provides diagnostic test kits, culture media, and data management software to detect pathogens, toxins, allergens, and spoilage organisms, serving food and feed processors, agricultural operations, and regulatory agencies. The Animal Safety segment provides veterinary instruments, animal care products, pharmaceuticals, pest control solutions, and genomics testing services to livestock producers, veterinarians, and retailers.
Company profile, executives and historyNeogen stock: common questions
What is Neogen's stock price?
NEOG closed at $11.19 on Nov 12, 2026, down 3.53% on the day. Over the past 52 weeks it traded between $5.37 and $14.26.
What is Neogen's market cap?
Neogen was worth $2.44B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is NEOG's P/E ratio?
Neogen lost money over the twelve months to Aug 31, 2026 (diluted EPS -$0.25), so it has no meaningful P/E ratio.
How much revenue does Neogen make?
Neogen reported revenue of $883.99M for the twelve months to Aug 31, 2026, down 0.3% from a year earlier.
Does Neogen pay a dividend?
No. Neogen has not paid a cash dividend over the last twelve months.
When does Neogen report earnings next?
Neogen is expected to report Q2 FY2027 results on Jan 7, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has NEOG stock performed over the past year?
Including dividends, NEOG returned +73.0% over the past year, against +12.0% for the S&P 500.
How many NEOG shares are sold short?
13M shares were sold short at the latest FINRA report, 5.86% of the float, or 4.8 days of average trading volume.
Who are Neogen's competitors?
Companies most similar to Neogen by business, industry and size include QDEL, IDXX, LNTH, MYGN, TECH.
See a number that looks wrong?